{"title":"Risque nucléaire: les pharmaciens ont les clés des antidotes","authors":"Valérie Lequien","doi":"10.1016/S1769-7344(11)70346-8","DOIUrl":"10.1016/S1769-7344(11)70346-8","url":null,"abstract":"","PeriodicalId":92863,"journal":{"name":"Actualites pharmaceutiques hospitalieres","volume":"7 26","pages":"Page 6"},"PeriodicalIF":0.0,"publicationDate":"2011-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1769-7344(11)70346-8","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56673942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Les préparations buvables en pédiatrie","authors":"Mathieu Bay, Céline Saint-Laurent, Antoine Dupuis","doi":"10.1016/S1769-7344(11)70353-5","DOIUrl":"10.1016/S1769-7344(11)70353-5","url":null,"abstract":"<div><p>Parce qu’ils sont coûteux, peu rentables à développer, la gamme des médicaments à usage pédiatrique est restreinte. Mais adapter à l’enfant des spécialités destinées aux adultes pose des problèmes de sécurité et d’administration. Les préparations pédiatriques sous forme buvable permettent une meilleure adaptation aux modifications de posologie et une administration plus aisée pour le personnel hospitalier.</p></div>","PeriodicalId":92863,"journal":{"name":"Actualites pharmaceutiques hospitalieres","volume":"7 26","pages":"Pages 20-24"},"PeriodicalIF":0.0,"publicationDate":"2011-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1769-7344(11)70353-5","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56674698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Médicament sous autorisation temporaire d’utilisation ayant obtenu une autorisation de mise sur le marché en 2010","authors":"Anne-Charlotte Teisseyre, Blandine Juillard-Condat","doi":"10.1016/S1769-7344(11)70334-1","DOIUrl":"10.1016/S1769-7344(11)70334-1","url":null,"abstract":"","PeriodicalId":92863,"journal":{"name":"Actualites pharmaceutiques hospitalieres","volume":"7 25","pages":"Page 35"},"PeriodicalIF":0.0,"publicationDate":"2011-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1769-7344(11)70334-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"100328678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Analyse de l’ordonnance, pharmacie clinique : des fondamentaux qui justifient notre ancrage dans la prise en charge médicamenteuse des patients","authors":"Catherine Montagnier-Petrissans","doi":"10.1016/S1769-7344(11)70317-1","DOIUrl":"10.1016/S1769-7344(11)70317-1","url":null,"abstract":"","PeriodicalId":92863,"journal":{"name":"Actualites pharmaceutiques hospitalieres","volume":"7 25","pages":"Page 1"},"PeriodicalIF":0.0,"publicationDate":"2011-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1769-7344(11)70317-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56672040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Les nouveautés thérapeutiques en 2009–2010","authors":"Voa Ratsimbazafy","doi":"10.1016/S1769-7344(11)70329-8","DOIUrl":"10.1016/S1769-7344(11)70329-8","url":null,"abstract":"<div><p>Pour 2009–2010, les innovations médicamenteuses ayant obtenu une autorisation de mise sur le marché (AMM) traitées dans ce dossier annuel concernent dix disciplines. Quinze spécialités pharmaceutiques sont ainsi passées en revue, avec les résultats des essais cliniques menés et ce que la Commission de la transparence a évalué comme niveau d’amélioration du service médical rendu. Une vingtaine de médicaments ont reçu entre le 1er janvier et le 30 juin 2010 une autorisation temporaire d’utilisation (ATU) nominative ou de cohorte. Concernant les dispositifs médicaux, deux techniques innovantes sont étudiées dans le domaine de la neurochirurgie et de la chirurgie orthopédique.</p></div>","PeriodicalId":92863,"journal":{"name":"Actualites pharmaceutiques hospitalieres","volume":"7 25","pages":"Page 9"},"PeriodicalIF":0.0,"publicationDate":"2011-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1769-7344(11)70329-8","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56672822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}